Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (106)

2024

  1. Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

    Clinical Cancer Research, Vol. 30, Núm. 5, pp. 975-983

  2. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era

    Current Opinion in Obstetrics and Gynecology, Vol. 36, Núm. 2, pp. 104-111

2023

  1. Advances in immunotherapy for cervical cancer

    Therapeutic Advances in Medical Oncology, Vol. 15

  2. Advances in immunotherapy in cervical cancer

    International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 403-413

  3. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  4. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370

  5. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  6. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation

    International Journal of Gynecological Cancer, Vol. 32, Núm. 9, pp. 1196-1200

  2. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  3. Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci

    Journal of Infection, Vol. 85, Núm. 2, pp. 137-146

  4. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  5. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  6. Treatment strategies in cervical cancer: treatment of advanced disease

    Journal of Cancer Metastasis and Treatment, Vol. 8

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

    Nature Communications, Vol. 12, Núm. 1

  3. Infective Endocarditis in Patients on Chronic Hemodialysis

    Journal of the American College of Cardiology, Vol. 77, Núm. 13, pp. 1629-1640

  4. Microbiota-based markers predictive of development of Clostridioides difficile infection

    Nature Communications, Vol. 12, Núm. 1

  5. Overview of virus and cancer relationships. Position paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 525-555

2020

  1. Biomarkers of fungal infection: Expert opinion on the current situation

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 1, pp. 1-10